CDK4 polyclonal antibody 
Datasheet
COA
MSDS
SHIP
Product Name :
CDK4 polyclonal antibody Background :
Cell cycle progression is controlled in part by a family of cyclin proteins and cyclin dependent kinases (Cdks). Cdk proteins work in concert with the cyclins to phosphorylate key substrates involved in each phase of cell cycle progression. Another family of proteins, Cdk inhibitors, also plays a role in regulating the cell cycle by binding to cyclin-Cdk complexes and modulating their activity. Several Cdk proteins have been identified, including Cdk2–Cdk8, PCTAIRE-1–3, PITALRE and PITSLRE. Cdk4, in complex with D-type cyclins, is thought to regulate cell growth during the G1 phase of the cell cycle. This association with a D-type cyclin upregulates Cdk4 activity, whereas binding to the Cdk inhibitor p16 downregulates Cdk4 activity. Activation of the Cdk4-cyclin complexes requires phosphorylation on a single threonyl residue of Cdk4, catalyzed by a Cdk-activating protein (CAK) Product :
Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2 Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. Specificity :
CDK4 polyclonal antibody detects endogenous levels of CDK4 protein. Immunogen :
Recombinant full length Human CDK4. Conjugate :
Unconjugated Modification :
Unmodification
CDK4 polyclonal antibody Background :
Cell cycle progression is controlled in part by a family of cyclin proteins and cyclin dependent kinases (Cdks). Cdk proteins work in concert with the cyclins to phosphorylate key substrates involved in each phase of cell cycle progression. Another family of proteins, Cdk inhibitors, also plays a role in regulating the cell cycle by binding to cyclin-Cdk complexes and modulating their activity. Several Cdk proteins have been identified, including Cdk2–Cdk8, PCTAIRE-1–3, PITALRE and PITSLRE. Cdk4, in complex with D-type cyclins, is thought to regulate cell growth during the G1 phase of the cell cycle. This association with a D-type cyclin upregulates Cdk4 activity, whereas binding to the Cdk inhibitor p16 downregulates Cdk4 activity. Activation of the Cdk4-cyclin complexes requires phosphorylation on a single threonyl residue of Cdk4, catalyzed by a Cdk-activating protein (CAK) Product :
Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2 Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. Specificity :
CDK4 polyclonal antibody detects endogenous levels of CDK4 protein. Immunogen :
Recombinant full length Human CDK4. Conjugate :
Unconjugated Modification :
Unmodification
-
WesternBlot (WB) analysis of CDK4 polyclonal antibody -
Immunohistochemistry (IHC) analysis of CDK4 pAb in paraffin-embedded Human Esophageal Cancer tissue.
Cyclic fluid shear stress promotes osteoblastic cells proliferation through ERK5 signaling pathway
PMCID: Pubmed No.:22286747
Achyranthes bidentata polysaccharides induce chondrocyte proliferation via the promotion of the G1/S cell cycle transition.
PMCID: Pubmed No.:23340819
Oxidized Low-Density Lipoprotein Induces Hematopoietic Stem Cell Senescence
PMCID: Pubmed No.:23620010
Iso-suillin isolated from Suillus luteus, induces G1 phase arrest and apoptosis in human hepatoma SMMC-7721 cells.
PMCID: Pubmed No.:24606477
Fangchinoline as a kinase inhibitor targets FAK and suppresses FAK-mediated signaling pathway in A549
PMCID: Pubmed No.:25539072
Oxymatrine targets EGFRp-Tyr845 and inhibits EGFR-related signaling pathways to suppress the proliferation and invasion of gastric cancer cells
PMCID: Pubmed No.:25527205
MCM2 is a therapeutic target of lovastatin in human non-small cell lung carcinomas
PMCID: Pubmed No.:25738322
TPX2 Level Correlates with Hepatocellular Carcinoma Cell Proliferation, Apoptosis, and EMT
PMCID: Pubmed No.:26025609
Wogonoside induces growth inhibition and cell cycle arrest via promoting the expression and binding activity of GATA-1 in chronic myelogenous leukemia cells
PMCID: Pubmed No.:26104856
Macrophage migration inhibitory factor in the regulation of myoblast proliferation and differentiation
PMCID: Pubmed No.:26927414
Fangchinoline as a kinase inhibitor targets FAK and suppresses FAK-mediated signaling pathway in A549
PMCID: Pubmed No.:25539072
Oxymatrine targets EGFRp-Tyr845 and inhibits EGFR-related signaling pathways to suppress the proliferation and invasion of gastric cancer cells
PMCID: Pubmed No.:25527205
Macrophage migration inhibitory factor in the regulation of myoblast proliferation and differentiation
PMCID: Pubmed No.:26927414
Iso-suillin isolated from Suillus luteus, induces G1 phase arrest and apoptosis in human hepatoma SMMC-7721 cells.
PMCID: Pubmed No.:24606477
Wogonoside induces growth inhibition and cell cycle arrest via promoting the expression and binding activity of GATA-1 in chronic myelogenous leukemia cells
PMCID: Pubmed No.:26104856
MCM2 is a therapeutic target of lovastatin in human non-small cell lung carcinomas
PMCID: Pubmed No.:25738322
Fangchinoline as a kinase inhibitor targets FAK and suppresses FAK-mediated signaling pathway in A549
PMCID: Pubmed No.:25539072
Activation of PPARγ inhibits HDAC1-mediated pulmonary arterial smooth muscle cell proliferation and its potential mechanisms
PMCID: Pubmed No.:28867608
Oxymatrine targets EGFRp-Tyr845 and inhibits EGFR-related signaling pathways to suppress the proliferation and invasion of gastric cancer cells
PMCID: Pubmed No.:25527205
TPX2 Level Correlates with Hepatocellular Carcinoma Cell Proliferation, Apoptosis, and EMT
PMCID: Pubmed No.:26025609
Long non-coding RNA AK058003, as a precursor of miR-15a, interacts with HuR to inhibit the expression of Υ-synuclein in hepatocellular carcinoma cells
PMCID: Pubmed No.:28035067
ST3Gal IV Mediates the Growth and Proliferation of Cervical Cancer Cells In Vitro and In Vivo Via the Notch/p21/CDKs Pathway
PMCID: Pubmed No.:33598419
miR-34a-5p inhibits the malignant progression of KSHV-infected SH-SY5Y cells by targeting c-fos
PMCID: Pubmed No.:35444864
Up-Regulation of SH3TC2 Induced by YTHDF1 Predicts Poor Outcome and Facilitates Cell-Cycle Progress in Colorectal Cancer
PMCID: Pubmed No.:36568637
Parthenolide inhibits proliferation of cells infected with Kaposi’s sarcoma-associated herpesvirus by suppression of the NF-κB signaling pathway
PMCID: Pubmed No.:36609933
Bioworld Biotech only provide peptides for our antibodies and do not provide additional peptide customization services.
Price/Size :
USD 368/1mg/vial
Tips:
For phospho antibody, we provide phospho peptide（0.5mg) and non-phospho peptide(0.5mg).Describe :
Blocking peptides are peptides that bind specifically to the target antibody and block antibody binding. These peptide usually contains the epitope recognized by the antibody. Antibodies bound to the blocking peptide no longer bind to the epitope on the target protein. This mechanism is useful when non-specific binding is an issue, for example, in Western blotting (WB) and Immunohistochemistry (IHC). By comparing the staining from the blocked antibody versus the antibody alone, one can see which staining is specific; Specific binding will be absent from the western blot or IHC performed with the neutralized antibody.Formula:
Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 10 mg/ml.The purity is >90%,tested by HPLC and MS.
Storage:
The freeze-dried powder is more stable. For short time at 2-8°C. For long term storage store at -20°C.
Note :
This product is for research use only (RUO only). Not for use in diagnostic or therapeutic procedures.